Weinberg's Pharma Omnium sells Biodim subsidiary
France-based Pharma Omnium International, a portfolio company of Weinberg Capital Partners (WCP), has sold its subsidiary Laboratoire Biodim to pharmaceutical business NuPharm, backed by Apax Partners.
More on Exits
Partners Group buys Parmaco from Terra Firma-led group
Vendors reportedly sought a valuation of between €800m-1bn for the company
Capidea buys toy company Maki from Industri Udvikling
Industri Udvikling had backed Maki since August 2017 and owned a 40% stake
HTGF, Neuhaus Partners sell stakes in Next Kraftwerke
Shell acquires the virtual power plants operator one month buying VC-backed Ubitricity
Latour buys Omni-Pac from Motion Equity and Arkéa
Omni-Pac's management team and Motion Equity Partners reinvest alongside Latour Capital
Latest News
L Catterton acquires Birkenstock
German footwear company is reportedly valued at around €4bn and drew interest from several PE buyers
Hiro Capital invests $15m in three gaming studios
Funding will help the studios expand their development pipelines and accelerate global growth
Partners Group buys Parmaco from Terra Firma-led group
Vendors reportedly sought a valuation of between €800m-1bn for the company
P101 invests €6m in series-B for Bipi Mobility
P101 deploys capital from its Programma 102 and Italia 500 vehicles for the deal